The Cancer Research Institute is deeply grateful for the leadership and guidance of its volunteer Board of Trustees, which includes highly accomplished leaders in diverse professions. Trustees make significant, long-term commitments in support of CRI's mission through strategic governance, active participation in CRI initiatives, and financial support.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).